Literature DB >> 23665358

Breaking the symmetry: immune enhancement increases persistence of dengue viruses in the presence of asymmetric transmission rates.

Luis Mier-y-Teran-Romero1, Ira B Schwartz, Derek A T Cummings.   

Abstract

The dengue viruses exist as four antigenically distinct serotypes. These four serotypes co-circulate and interact with each other through multiple immune-mediated mechanisms. Though the majority of previous efforts to understand the transmission dynamics of dengue have assumed identical characteristics for these four serotypes, empirical data suggests that they differ from one another in important ways. Here, we examine dynamics and persistence in models that do not assume symmetry between the dengue viruses. We find that for serotype transmission rates that are only slightly asymmetric, increased transmissibility of secondary infections through immune enhancement increases the persistence of all dengue viruses in opposition to findings in symmetric models. We identify an optimal magnitude of immune enhancement that maximizes the probability of persistence of all four serotypes. In contrast to other pathogen systems where heterogeneity between serotypes in transmissibility facilitates competitive exclusion (Bremmermann and Thieme, 1989), here we find that in the presence of Antibody Dependent Enhancement (ADE) heterogeneity can increase the persistence of multiple serotypes of dengue.
Copyright © 2013 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Antibody dependent enhancement; Dengue; Dengue vaccine; Serotypical asymmetry

Mesh:

Substances:

Year:  2013        PMID: 23665358      PMCID: PMC3782297          DOI: 10.1016/j.jtbi.2013.04.036

Source DB:  PubMed          Journal:  J Theor Biol        ISSN: 0022-5193            Impact factor:   2.691


  36 in total

1.  Cost-effectiveness of a pediatric dengue vaccine.

Authors:  Donald S Shepard; Jose A Suaya; Scott B Halstead; Michael B Nathan; Duane J Gubler; Richard T Mahoney; Daniel N C Wang; Martin I Meltzer
Journal:  Vaccine       Date:  2004-03-12       Impact factor: 3.641

2.  The effect of antibody-dependent enhancement on the transmission dynamics and persistence of multiple-strain pathogens.

Authors:  N Ferguson; R Anderson; S Gupta
Journal:  Proc Natl Acad Sci U S A       Date:  1999-01-19       Impact factor: 11.205

3.  Competitive exclusion in a vector-host model for the dengue fever.

Authors:  Z Feng; J X Velasco-Hernández
Journal:  J Math Biol       Date:  1997-05       Impact factor: 2.259

4.  A prospective study of dengue infections in Bangkok.

Authors:  D S Burke; A Nisalak; D E Johnson; R M Scott
Journal:  Am J Trop Med Hyg       Date:  1988-01       Impact factor: 2.345

5.  Failure of secondary infection with American genotype dengue 2 to cause dengue haemorrhagic fever.

Authors:  D M Watts; K R Porter; P Putvatana; B Vasquez; C Calampa; C G Hayes; S B Halstead
Journal:  Lancet       Date:  1999-10-23       Impact factor: 79.321

6.  Dynamics of dengue disease severity determined by the interplay between viral genetics and serotype-specific immunity.

Authors:  Molly OhAinle; Angel Balmaseda; Alexander R Macalalad; Yolanda Tellez; Michael C Zody; Saira Saborío; Andrea Nuñez; Niall J Lennon; Bruce W Birren; Aubree Gordon; Matthew R Henn; Eva Harris
Journal:  Sci Transl Med       Date:  2011-12-21       Impact factor: 17.956

7.  Serotype-specific dengue virus circulation and dengue disease in Bangkok, Thailand from 1973 to 1999.

Authors:  Ananda Nisalak; Timothy P Endy; Suchitra Nimmannitya; Siripen Kalayanarooj; Usa Thisayakorn; Robert M Scott; Donald S Burke; Charles H Hoke; Bruce L Innis; David W Vaughn
Journal:  Am J Trop Med Hyg       Date:  2003-02       Impact factor: 2.345

8.  Efficiency of dengue serotype 2 virus strains to infect and disseminate in Aedes aegypti.

Authors:  Philip M Armstrong; Rebeca Rico-Hesse
Journal:  Am J Trop Med Hyg       Date:  2003-05       Impact factor: 2.345

Review 9.  The origin, emergence and evolutionary genetics of dengue virus.

Authors:  Edward C Holmes; S Susanna Twiddy
Journal:  Infect Genet Evol       Date:  2003-05       Impact factor: 3.342

10.  Risk factors in dengue shock syndrome: a prospective epidemiologic study in Rayong, Thailand. I. The 1980 outbreak.

Authors:  N Sangkawibha; S Rojanasuphot; S Ahandrik; S Viriyapongse; S Jatanasen; V Salitul; B Phanthumachinda; S B Halstead
Journal:  Am J Epidemiol       Date:  1984-11       Impact factor: 4.897

View more
  7 in total

1.  Potential opportunities and perils of imperfect dengue vaccines.

Authors:  Isabel Rodriguez-Barraquer; Luis Mier-y-Teran-Romero; Ira B Schwartz; Donald S Burke; Derek A T Cummings
Journal:  Vaccine       Date:  2013-11-19       Impact factor: 3.641

2.  The impact of coinfections and their simultaneous transmission on antigenic diversity and epidemic cycling of infectious diseases.

Authors:  Xu-Sheng Zhang; Ke-Fei Cao
Journal:  Biomed Res Int       Date:  2014-06-22       Impact factor: 3.411

3.  Characterizing the likelihood of dengue emergence and detection in naïve populations.

Authors:  Rebecca C Christofferson; Christopher N Mores; Helen J Wearing
Journal:  Parasit Vectors       Date:  2014-06-23       Impact factor: 3.876

4.  Are we modelling the correct dataset? Minimizing false predictions for dengue fever in Thailand.

Authors:  M Aguiar; R Paul; A Sakuntabhai; N Stollenwerk
Journal:  Epidemiol Infect       Date:  2014-11       Impact factor: 2.451

5.  The Role of Serotype Interactions and Seasonality in Dengue Model Selection and Control: Insights from a Pattern Matching Approach.

Authors:  Quirine A Ten Bosch; Brajendra K Singh; Muhammad R A Hassan; Dave D Chadee; Edwin Michael
Journal:  PLoS Negl Trop Dis       Date:  2016-05-09

6.  The ratio of single to co-colonization is key to complexity in interacting systems with multiple strains.

Authors:  Erida Gjini; Sten Madec
Journal:  Ecol Evol       Date:  2021-06-06       Impact factor: 2.912

Review 7.  Vaccine- and natural infection-induced mechanisms that could modulate vaccine safety.

Authors:  Ronald N Kostoff; Darja Kanduc; Alan L Porter; Yehuda Shoenfeld; Daniela Calina; Michael B Briggs; Demetrios A Spandidos; Aristidis Tsatsakis
Journal:  Toxicol Rep       Date:  2020-10-22
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.